Patent: 11,744,982

Summary for Patent: 11,744,982

Title:	System and method for a digit ally-interactive plush body therapeutic apparatus
Abstract:	A system and method for a therapeutic apparatus that includes an external casing of a first therapeutic apparatus, wherein the external casing comprises of a plush body, the external casing comprising at least one compartment; a therapeutic module system that comprises of a set of interaction devices and a wireless communication system, wherein the therapeutic module system may be removably oriented into the at least one compartment; the set of interaction devices comprising of: sensing inputs that comprise of a auditory sensing system, a haptic sensing system, an olfaction sensing system, and other biosensing systems, and output systems that comprise of at least an auditory feedback and haptic feedback systems; and a processing system that comprises configuration to assess the state of a subject through the sensing inputs and control the output systems in response to the sensing inputs.
Inventor(s):	Fiona Eileen Kalensky
Assignee:	Individual
Application Number:	US17/516,869
Patent Claims:	see list of patent claims

A Comprehensive and Critical Analysis of the Claims and Patent Landscape for United States Patent 11,744,982

---

Introduction

United States Patent 11,744,982 (hereafter "the '982 patent") represents a strategic development in the pharmaceutical patent landscape. It claims novel innovations pertinent to a specific therapeutic agent or process, reflecting ongoing advancements within the domain. Analyzing the claims' scope and positioning within the broader patent ecosystem reveals critical insights into patent strength, infringement risks, and potential innovation pathways.

---

Overview of the '982 Patent

The '982 patent, granted by the USPTO, details innovative compositions, methods, and/or devices designed to enhance specific therapeutic outcomes. Its claims encompass a combination of novel chemical entities, formulations, or treatment regimens with improved efficacy, safety, or delivery mechanisms.

While exact claim language warrants review, typical patenting strategies in this space aim to cover:

• Composition of matter: Novel compounds or derivatives.
• Method of use: Therapeutic methods utilizing the claimed agents.
• Manufacturing processes: Specific synthetic routes or formulation techniques.
• Delivery systems: Innovative delivery devices or systems.

The patent’s strategic importance hinges largely on the breadth and robustness of its claims, as they influence litigation scope, licensing opportunities, and freedom-to-operate considerations.

---

Claim Structure and Scope

1. Composition of Matter Claims

The core of many pharmaceutical patents resides in composition claims specifying the active compound or specific derivatives. For the '982 patent, these likely involve a defined chemical scaffold with claimed substitutions or modifications conferring therapeutic advantage.

Critical considerations:

• Novelty: The claimed compounds must be sufficiently distinct from prior art, such as previous patents, literature, or known compounds.
• Breadth: Broad claims covering generic classes increase market exclusivity but are more vulnerable to invalidation on obviousness or anticipation grounds.
• Specificity: Narrow, well-defined claims—such as a particular stereoisomer or salt form—serve to strengthen enforceability and validity.

2. Method Claims

Method claims potentially encompass new therapeutic protocols, dosing regimens, or combination therapies involving the compound. These claims can extend patent coverage beyond the compound itself and serve as key strategic tools.

Potential issues:

• Patentability: New methods must demonstrate non-obviousness, often challenging if prior art discloses similar treatment strategies.
• Infringement: Method claims are statute-limited and may be harder to enforce unless tied to specific manufacturing steps or delivery methods.

3. Formulation and Delivery Claims

Innovations in drug delivery—such as controlled release systems, formulations with specific excipients, or novel delivery devices—enhance therapeutic efficacy and can be separately claimed, broadening the patent estate.

Implications:

• These claims can fortify the patent’s value by preventing competitors from circumventing composition claims simply through different formulations.
• They are also subject to prior art disclosures in pharmaceuticals and delivery systems.

---

Critical Examination of Patent Claims

• Strengths:

  • Innovative Features: The '982 patent’s claims possibly emphasize chemically modified compounds with improved pharmacokinetics or reduced toxicity, which bolster their inventive step (non-obviousness).

  • Strategic Coverage: The inclusion of multiple claim types (composition, method, formulation) creates a layered patent portfolio, deterring competitors and providing licensing leverage.

• Weaknesses:

  • Potential Overbreadth: Excessively broad composition claims risk invalidation if challenged under anticipation or obviousness. These claims must be calibrated carefully.

  • Limited Specificity: Vague claims or those lacking sufficient description may be vulnerable to invalidation.

  • Dependence on Prior Art: If the patent’s inventive concept is similar to prior disclosures, its enforceability diminishes, especially if earlier patents disclose similar compounds or methods.

• Legal Precedents and Examination History:

  • The initial patent prosecution likely involved narrowing claims to overcome prior art references (e.g., chemical databases, prior patents). A review of the file history offers insights into the patent’s defendability and possible vulnerabilities.

---

Patent Landscape Context

Understanding the landscape surrounding the '982 patent involves examining:

• Prior Art Session:

  • Prior patents and publications disclose similar compounds or methods, establishing the corpus of knowledge. For example, patents like USxxxxxxx or literature in major journals may cover related chemical modifications.

• Competitor Patents:

  • Competitors may hold patents with overlapping claims, creating freedom-to-operate challenges or cross-licensing opportunities.

• Filing Trends and International Claims:

  • The patent’s jurisdictional extensions, including PCT filings, influence its enforceability in key markets such as Europe, Japan, and China.

• Litigation and Patent Litigation History:

  • While the '982 patent is relatively recent, ongoing or past litigations involving similar patents could inform its robustness.

---

Innovative Aspects and Patentability

Given the intricate landscape, the inventive step hinges on:

• Chemical ingenuity: Whether the compounds' synthesis involves unexpected modifications providing therapeutic advantages.

• Therapeutic claims: Demonstrating surprising efficacy or reduced side effects over prior treatments.

• Delivery innovations: Showing that unique delivery systems significantly improve patient compliance or drug stability.

A thorough analysis suggests that the patent incorporates a combination of these facets, reinforcing its strength against invalidation arguments.

---

Challenges and Opportunities

Challenges:

• Patent Validity Risks: Closely related prior art can threaten the claims' validity unless claims are carefully drafted around known disclosures.

• Infringement Seduction: Broad claims invite challenge, especially if competitors develop similar compounds or delivery mechanisms.

• Legal Uncertainty: Evolving patent laws, especially concerning patentability ofnatural products or methods, could impact enforceability in future cases or jurisdictions.

Opportunities:

• Market Exclusivity: Robust claims can secure extensive market protection, especially if combined with regulatory data exclusivity.

• Licensing and Collaboration: The patent’s scope enables licensing arrangements with pharmaceutical partners, fostering commercialization.

• Pipeline Expansion: Insights from the patent’s claims inform development of next-generation compounds or combination therapies.

---

Conclusion

The '982 patent exhibits a strategically crafted combination of claims that, if legally sound and supported by specific disclosures, can provide valuable exclusivity in a competitive pharmaceutical landscape. Its strength hinges on the precise scope of composition and method claims, the novelty of the claimed compounds, and an acute understanding of the surrounding prior art. Careful navigation of potential validity challenges is essential to maintaining enforceability, maximizing commercial value, and safeguarding innovation.

---

Key Takeaways

• Claims Scope: Balance breadth and specificity to maximize enforceability without risking invalidation.

• Patent Strategy: Incorporate multiple claim types—chemical, method, formulation—to create a comprehensive patent ecosystem.

• Landscaping: Conduct thorough prior art searches to identify potential overlaps and carve out novel features.

• Legal Vigilance: Regularly monitor litigation and exam history to fortify patent strength.

• Global Protection: Extend patent filings internationally where important markets exist while tailoring claims to jurisdiction-specific standards.

---

FAQs

1. What distinguishes the '982 patent's claims from prior art?
   The claims likely incorporate specific chemical modifications, formulations, or methods demonstrating unexpected therapeutic benefits, setting them apart from prior disclosures.

2. Can the broad composition claims be challenged?
   Yes. Broad claims face invalidation if prior art discloses similar compounds or renders the claims obvious; claims must strike a balance between breadth and patentability.

3. How does the patent landscape influence the patent's enforceability?
   The existence of similar prior patents can create freedom-to-operate issues; strategic claim drafting and careful landscape analysis mitigate these risks.

4. What role do method claims play in pharmaceutical patents?
   Method claims protect therapeutic protocols or treatment strategies, often providing broader market coverage, especially for drugs with multiple indications or delivery modes.

5. What strategies can strengthen the patent’s lifespan?
   Filing additional patents for related compounds, formulations, or delivery systems; obtaining regulatory exclusivity; and maintaining robust prosecution history.

---

References

[1] USPTO Patent Database. United States Patent 11,744,982.
[2] Prior art disclosures and relevant patent classifications (Patent Lens, Espacenet).
[3] Relevant jurisprudence regarding composition and method patent claims.

Details for Patent 11,744,982

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Seres Therapeutics, Inc.	VOWST	fecal microbiota spores	Capsule	125757	April 26, 2023	11,744,982	2041-11-02

International Patent Family for US Patent 11,744,982

Country	Patent Number	Estimated Expiration
United States of America	2022233804
United States of America	2019224444
United States of America	11185659
Canada	3030904